PUBLISHER: QYResearch | PRODUCT CODE: 1873370
PUBLISHER: QYResearch | PRODUCT CODE: 1873370
Clinical Trial Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Clinical Trial Imaging was estimated to be worth US$ 1579 million in 2024 and is forecast to a readjusted size of US$ 2501 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.
The core manufacturers of clinical trial imaging in the world include Clario, ICON, McLaren, Calyx and BioTelemetry. The top five companies hold about 60% of the shares. North America is the largest market, with a share of about 33%, followed by Europe and Asia Pacific, each with a share of about 27%. In terms of product type, central imaging services are the largest market segment, with a share of about 70%. In terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of subjects are fully guaranteed and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of trial results.
Clinical trial imaging plays an important role in different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.
For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.
In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and evaluation of treatment effects. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.
With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.
The driving factors of the clinical trial imaging market mainly include the following:
Technological progress: innovation drives core growth
High-precision and multimodal imaging technology
Breakthroughs in technologies such as MRI, CT, and PET: High-resolution imaging technology (such as 3T MRI and ultra-low-dose CT) provides more accurate anatomical and functional information, which helps early diagnosis of diseases and efficacy evaluation.
Multimodal fusion: The fusion technology of CT and MRI, PET and CT, combined with anatomical and metabolic information, significantly improves diagnostic sensitivity, such as in tumor staging.
Artificial Intelligence and Automation
AI-assisted analysis: Deep learning algorithms can automatically detect lesions (such as lung nodules and breast calcifications), reduce human errors, and improve diagnostic efficiency.
Process Automation: AI optimizes scanning protocols and automatically generates reports, shortens clinical trial cycles, and reduces costs.
Portable and Real-time Imaging
Portable ultrasound equipment: Suitable for bedside examinations and remote areas, expanding the coverage of clinical trials.
Real-time imaging technology: such as ultrasound elastic imaging, dynamically monitors changes in tissue hardness, and provides instant feedback for diseases such as liver fibrosis.
Policy support: Create a favorable development environment
Improvement of regulatory framework
FDA, NMPA and other agencies: Ensure the safety and effectiveness of equipment through strict approval processes, such as requiring that Class III medical imaging equipment must pass clinical trials before registration.
International Standard Coordination: Promote imaging protocols and data standardization (such as DICOM format) and promote multi-center trial data sharing.
Funding and Incentives
Government research funding: For example, China's "14th Five-Year Plan" special support for medical imaging technology to accelerate technology transformation.
Tax incentives and subsidies: Encourage corporate R&D and innovation, such as providing financial subsidies for localization projects of high-end imaging equipment.
Growth in medical demand: changes in population and disease structure
Aging and chronic disease burden
High incidence of cancer and neurodegenerative diseases: The global incidence of cancer is rising, driving the demand for early screening and efficacy monitoring.
Demand for precision medicine: Individualized treatment relies on high-precision imaging (such as molecular imaging in tumor targeted therapy).
New drug development and clinical trial expansion
Innovative drug development boom: The number of new drugs under development has surged globally, and the demand for imaging in clinical trials has increased accordingly.
Rare diseases and real-world research: Imaging technology helps small sample size trials and long-term efficacy tracking.
The growth of the clinical trial imaging market is the result of technological innovation, policy dividends, demand upgrades and the evolution of the competitive landscape. In the future, with the deep integration of AI, multimodal imaging and cloud technology, the market will accelerate its development towards intelligence and precision. At the same time, the rise of local companies will reshape the global competitive landscape and inject new vitality into the industry.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trial Imaging by region & country, by Type, and by Application.
The Clinical Trial Imaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging.
Market Segmentation
By Company
- ICON
- ERT
- McLaren
- Bioclinica
- Parexel
- BioTelemetry
- ProScan Imaging
- Imaging Endpoints
- Radiant Sage
- Micron, Inc.
- Intrinsic Imaging
- Median Technologies
- Cardiovascular Imaging Technologies
- Banook Medical
- IXICO
- Tigermed
- Runda Medical
- Konica Minolta
- Keosys
Segment by Type
- In-house Imaging Service
- Central Imaging Service
Segment by Application
- Pharmaceutical Companies
- Biotechnology Companies
- Academic Institutes
- Others
By Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Clinical Trial Imaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Clinical Trial Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Clinical Trial Imaging in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 Clinical Trial Imaging Product Introduction
- 1.2 Global Clinical Trial Imaging Market Size Forecast (2020-2031)
- 1.3 Clinical Trial Imaging Market Trends & Drivers
- 1.3.1 Clinical Trial Imaging Industry Trends
- 1.3.2 Clinical Trial Imaging Market Drivers & Opportunity
- 1.3.3 Clinical Trial Imaging Market Challenges
- 1.3.4 Clinical Trial Imaging Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global Clinical Trial Imaging Players Revenue Ranking (2024)
- 2.2 Global Clinical Trial Imaging Revenue by Company (2020-2025)
- 2.3 Key Companies Clinical Trial Imaging Manufacturing Base Distribution and Headquarters
- 2.4 Key Companies Clinical Trial Imaging Product Offered
- 2.5 Key Companies Time to Begin Mass Production of Clinical Trial Imaging
- 2.6 Clinical Trial Imaging Market Competitive Analysis
- 2.6.1 Clinical Trial Imaging Market Concentration Rate (2020-2025)
- 2.6.2 Global 5 and 10 Largest Companies by Clinical Trial Imaging Revenue in 2024
- 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Imaging as of 2024)
- 2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 In-house Imaging Service
- 3.1.2 Central Imaging Service
- 3.2 Global Clinical Trial Imaging Sales Value by Type
- 3.2.1 Global Clinical Trial Imaging Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Clinical Trial Imaging Sales Value, by Type (2020-2031)
- 3.2.3 Global Clinical Trial Imaging Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Pharmaceutical Companies
- 4.1.2 Biotechnology Companies
- 4.1.3 Academic Institutes
- 4.1.4 Others
- 4.2 Global Clinical Trial Imaging Sales Value by Application
- 4.2.1 Global Clinical Trial Imaging Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Clinical Trial Imaging Sales Value, by Application (2020-2031)
- 4.2.3 Global Clinical Trial Imaging Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
- 5.1 Global Clinical Trial Imaging Sales Value by Region
- 5.1.1 Global Clinical Trial Imaging Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Clinical Trial Imaging Sales Value by Region (2020-2025)
- 5.1.3 Global Clinical Trial Imaging Sales Value by Region (2026-2031)
- 5.1.4 Global Clinical Trial Imaging Sales Value by Region (%), (2020-2031)
- 5.2 North America
- 5.2.1 North America Clinical Trial Imaging Sales Value, 2020-2031
- 5.2.2 North America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
- 5.3 Europe
- 5.3.1 Europe Clinical Trial Imaging Sales Value, 2020-2031
- 5.3.2 Europe Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Clinical Trial Imaging Sales Value, 2020-2031
- 5.4.2 Asia Pacific Clinical Trial Imaging Sales Value by Region (%), 2024 VS 2031
- 5.5 South America
- 5.5.1 South America Clinical Trial Imaging Sales Value, 2020-2031
- 5.5.2 South America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
- 5.6 Middle East & Africa
- 5.6.1 Middle East & Africa Clinical Trial Imaging Sales Value, 2020-2031
- 5.6.2 Middle East & Africa Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions Clinical Trial Imaging Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions Clinical Trial Imaging Sales Value, 2020-2031
- 6.3 United States
- 6.3.1 United States Clinical Trial Imaging Sales Value, 2020-2031
- 6.3.2 United States Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Clinical Trial Imaging Sales Value, 2020-2031
- 6.4.2 Europe Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China Clinical Trial Imaging Sales Value, 2020-2031
- 6.5.2 China Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan Clinical Trial Imaging Sales Value, 2020-2031
- 6.6.2 Japan Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea Clinical Trial Imaging Sales Value, 2020-2031
- 6.7.2 South Korea Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia Clinical Trial Imaging Sales Value, 2020-2031
- 6.8.2 Southeast Asia Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India Clinical Trial Imaging Sales Value, 2020-2031
- 6.9.2 India Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 ICON
- 7.1.1 ICON Profile
- 7.1.2 ICON Main Business
- 7.1.3 ICON Clinical Trial Imaging Products, Services and Solutions
- 7.1.4 ICON Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.1.5 ICON Recent Developments
- 7.2 ERT
- 7.2.1 ERT Profile
- 7.2.2 ERT Main Business
- 7.2.3 ERT Clinical Trial Imaging Products, Services and Solutions
- 7.2.4 ERT Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.2.5 ERT Recent Developments
- 7.3 McLaren
- 7.3.1 McLaren Profile
- 7.3.2 McLaren Main Business
- 7.3.3 McLaren Clinical Trial Imaging Products, Services and Solutions
- 7.3.4 McLaren Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.3.5 McLaren Recent Developments
- 7.4 Bioclinica
- 7.4.1 Bioclinica Profile
- 7.4.2 Bioclinica Main Business
- 7.4.3 Bioclinica Clinical Trial Imaging Products, Services and Solutions
- 7.4.4 Bioclinica Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.4.5 Bioclinica Recent Developments
- 7.5 Parexel
- 7.5.1 Parexel Profile
- 7.5.2 Parexel Main Business
- 7.5.3 Parexel Clinical Trial Imaging Products, Services and Solutions
- 7.5.4 Parexel Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.5.5 Parexel Recent Developments
- 7.6 BioTelemetry
- 7.6.1 BioTelemetry Profile
- 7.6.2 BioTelemetry Main Business
- 7.6.3 BioTelemetry Clinical Trial Imaging Products, Services and Solutions
- 7.6.4 BioTelemetry Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.6.5 BioTelemetry Recent Developments
- 7.7 ProScan Imaging
- 7.7.1 ProScan Imaging Profile
- 7.7.2 ProScan Imaging Main Business
- 7.7.3 ProScan Imaging Clinical Trial Imaging Products, Services and Solutions
- 7.7.4 ProScan Imaging Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.7.5 ProScan Imaging Recent Developments
- 7.8 Imaging Endpoints
- 7.8.1 Imaging Endpoints Profile
- 7.8.2 Imaging Endpoints Main Business
- 7.8.3 Imaging Endpoints Clinical Trial Imaging Products, Services and Solutions
- 7.8.4 Imaging Endpoints Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.8.5 Imaging Endpoints Recent Developments
- 7.9 Radiant Sage
- 7.9.1 Radiant Sage Profile
- 7.9.2 Radiant Sage Main Business
- 7.9.3 Radiant Sage Clinical Trial Imaging Products, Services and Solutions
- 7.9.4 Radiant Sage Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.9.5 Radiant Sage Recent Developments
- 7.10 Micron, Inc.
- 7.10.1 Micron, Inc. Profile
- 7.10.2 Micron, Inc. Main Business
- 7.10.3 Micron, Inc. Clinical Trial Imaging Products, Services and Solutions
- 7.10.4 Micron, Inc. Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.10.5 Micron, Inc. Recent Developments
- 7.11 Intrinsic Imaging
- 7.11.1 Intrinsic Imaging Profile
- 7.11.2 Intrinsic Imaging Main Business
- 7.11.3 Intrinsic Imaging Clinical Trial Imaging Products, Services and Solutions
- 7.11.4 Intrinsic Imaging Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.11.5 Intrinsic Imaging Recent Developments
- 7.12 Median Technologies
- 7.12.1 Median Technologies Profile
- 7.12.2 Median Technologies Main Business
- 7.12.3 Median Technologies Clinical Trial Imaging Products, Services and Solutions
- 7.12.4 Median Technologies Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.12.5 Median Technologies Recent Developments
- 7.13 Cardiovascular Imaging Technologies
- 7.13.1 Cardiovascular Imaging Technologies Profile
- 7.13.2 Cardiovascular Imaging Technologies Main Business
- 7.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Products, Services and Solutions
- 7.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.13.5 Cardiovascular Imaging Technologies Recent Developments
- 7.14 Banook Medical
- 7.14.1 Banook Medical Profile
- 7.14.2 Banook Medical Main Business
- 7.14.3 Banook Medical Clinical Trial Imaging Products, Services and Solutions
- 7.14.4 Banook Medical Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.14.5 Banook Medical Recent Developments
- 7.15 IXICO
- 7.15.1 IXICO Profile
- 7.15.2 IXICO Main Business
- 7.15.3 IXICO Clinical Trial Imaging Products, Services and Solutions
- 7.15.4 IXICO Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.15.5 IXICO Recent Developments
- 7.16 Tigermed
- 7.16.1 Tigermed Profile
- 7.16.2 Tigermed Main Business
- 7.16.3 Tigermed Clinical Trial Imaging Products, Services and Solutions
- 7.16.4 Tigermed Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.16.5 Tigermed Recent Developments
- 7.17 Runda Medical
- 7.17.1 Runda Medical Profile
- 7.17.2 Runda Medical Main Business
- 7.17.3 Runda Medical Clinical Trial Imaging Products, Services and Solutions
- 7.17.4 Runda Medical Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.17.5 Runda Medical Recent Developments
- 7.18 Konica Minolta
- 7.18.1 Konica Minolta Profile
- 7.18.2 Konica Minolta Main Business
- 7.18.3 Konica Minolta Clinical Trial Imaging Products, Services and Solutions
- 7.18.4 Konica Minolta Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.18.5 Konica Minolta Recent Developments
- 7.19 Keosys
- 7.19.1 Keosys Profile
- 7.19.2 Keosys Main Business
- 7.19.3 Keosys Clinical Trial Imaging Products, Services and Solutions
- 7.19.4 Keosys Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
- 7.19.5 Keosys Recent Developments
8 Industry Chain Analysis
- 8.1 Clinical Trial Imaging Industrial Chain
- 8.2 Clinical Trial Imaging Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 Clinical Trial Imaging Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Clinical Trial Imaging Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.1.1 Methodology/Research Approach
- 10.2 Author Details
- 10.3 Disclaimer
List of Tables
- Table 1. Clinical Trial Imaging Market Trends
- Table 2. Clinical Trial Imaging Market Drivers & Opportunity
- Table 3. Clinical Trial Imaging Market Challenges
- Table 4. Clinical Trial Imaging Market Restraints
- Table 5. Global Clinical Trial Imaging Revenue by Company (2020-2025) & (US$ Million)
- Table 6. Global Clinical Trial Imaging Revenue Market Share by Company (2020-2025)
- Table 7. Key Companies Clinical Trial Imaging Manufacturing Base Distribution and Headquarters
- Table 8. Key Companies Clinical Trial Imaging Product Type
- Table 9. Key Companies Time to Begin Mass Production of Clinical Trial Imaging
- Table 10. Global Clinical Trial Imaging Companies Market Concentration Ratio (CR5 and HHI)
- Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Imaging as of 2024)
- Table 12. Mergers & Acquisitions, Expansion Plans
- Table 13. Global Clinical Trial Imaging Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
- Table 14. Global Clinical Trial Imaging Sales Value by Type (2020-2025) & (US$ Million)
- Table 15. Global Clinical Trial Imaging Sales Value by Type (2026-2031) & (US$ Million)
- Table 16. Global Clinical Trial Imaging Sales Market Share in Value by Type (2020-2025)
- Table 17. Global Clinical Trial Imaging Sales Market Share in Value by Type (2026-2031)
- Table 18. Global Clinical Trial Imaging Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
- Table 19. Global Clinical Trial Imaging Sales Value by Application (2020-2025) & (US$ Million)
- Table 20. Global Clinical Trial Imaging Sales Value by Application (2026-2031) & (US$ Million)
- Table 21. Global Clinical Trial Imaging Sales Market Share in Value by Application (2020-2025)
- Table 22. Global Clinical Trial Imaging Sales Market Share in Value by Application (2026-2031)
- Table 23. Global Clinical Trial Imaging Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
- Table 24. Global Clinical Trial Imaging Sales Value by Region (2020-2025) & (US$ Million)
- Table 25. Global Clinical Trial Imaging Sales Value by Region (2026-2031) & (US$ Million)
- Table 26. Global Clinical Trial Imaging Sales Value by Region (2020-2025) & (%)
- Table 27. Global Clinical Trial Imaging Sales Value by Region (2026-2031) & (%)
- Table 28. Key Countries/Regions Clinical Trial Imaging Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
- Table 29. Key Countries/Regions Clinical Trial Imaging Sales Value, (2020-2025) & (US$ Million)
- Table 30. Key Countries/Regions Clinical Trial Imaging Sales Value, (2026-2031) & (US$ Million)
- Table 31. ICON Basic Information List
- Table 32. ICON Description and Business Overview
- Table 33. ICON Clinical Trial Imaging Products, Services and Solutions
- Table 34. Revenue (US$ Million) in Clinical Trial Imaging Business of ICON (2020-2025)
- Table 35. ICON Recent Developments
- Table 36. ERT Basic Information List
- Table 37. ERT Description and Business Overview
- Table 38. ERT Clinical Trial Imaging Products, Services and Solutions
- Table 39. Revenue (US$ Million) in Clinical Trial Imaging Business of ERT (2020-2025)
- Table 40. ERT Recent Developments
- Table 41. McLaren Basic Information List
- Table 42. McLaren Description and Business Overview
- Table 43. McLaren Clinical Trial Imaging Products, Services and Solutions
- Table 44. Revenue (US$ Million) in Clinical Trial Imaging Business of McLaren (2020-2025)
- Table 45. McLaren Recent Developments
- Table 46. Bioclinica Basic Information List
- Table 47. Bioclinica Description and Business Overview
- Table 48. Bioclinica Clinical Trial Imaging Products, Services and Solutions
- Table 49. Revenue (US$ Million) in Clinical Trial Imaging Business of Bioclinica (2020-2025)
- Table 50. Bioclinica Recent Developments
- Table 51. Parexel Basic Information List
- Table 52. Parexel Description and Business Overview
- Table 53. Parexel Clinical Trial Imaging Products, Services and Solutions
- Table 54. Revenue (US$ Million) in Clinical Trial Imaging Business of Parexel (2020-2025)
- Table 55. Parexel Recent Developments
- Table 56. BioTelemetry Basic Information List
- Table 57. BioTelemetry Description and Business Overview
- Table 58. BioTelemetry Clinical Trial Imaging Products, Services and Solutions
- Table 59. Revenue (US$ Million) in Clinical Trial Imaging Business of BioTelemetry (2020-2025)
- Table 60. BioTelemetry Recent Developments
- Table 61. ProScan Imaging Basic Information List
- Table 62. ProScan Imaging Description and Business Overview
- Table 63. ProScan Imaging Clinical Trial Imaging Products, Services and Solutions
- Table 64. Revenue (US$ Million) in Clinical Trial Imaging Business of ProScan Imaging (2020-2025)
- Table 65. ProScan Imaging Recent Developments
- Table 66. Imaging Endpoints Basic Information List
- Table 67. Imaging Endpoints Description and Business Overview
- Table 68. Imaging Endpoints Clinical Trial Imaging Products, Services and Solutions
- Table 69. Revenue (US$ Million) in Clinical Trial Imaging Business of Imaging Endpoints (2020-2025)
- Table 70. Imaging Endpoints Recent Developments
- Table 71. Radiant Sage Basic Information List
- Table 72. Radiant Sage Description and Business Overview
- Table 73. Radiant Sage Clinical Trial Imaging Products, Services and Solutions
- Table 74. Revenue (US$ Million) in Clinical Trial Imaging Business of Radiant Sage (2020-2025)
- Table 75. Radiant Sage Recent Developments
- Table 76. Micron, Inc. Basic Information List
- Table 77. Micron, Inc. Description and Business Overview
- Table 78. Micron, Inc. Clinical Trial Imaging Products, Services and Solutions
- Table 79. Revenue (US$ Million) in Clinical Trial Imaging Business of Micron, Inc. (2020-2025)
- Table 80. Micron, Inc. Recent Developments
- Table 81. Intrinsic Imaging Basic Information List
- Table 82. Intrinsic Imaging Description and Business Overview
- Table 83. Intrinsic Imaging Clinical Trial Imaging Products, Services and Solutions
- Table 84. Revenue (US$ Million) in Clinical Trial Imaging Business of Intrinsic Imaging (2020-2025)
- Table 85. Intrinsic Imaging Recent Developments
- Table 86. Median Technologies Basic Information List
- Table 87. Median Technologies Description and Business Overview
- Table 88. Median Technologies Clinical Trial Imaging Products, Services and Solutions
- Table 89. Revenue (US$ Million) in Clinical Trial Imaging Business of Median Technologies (2020-2025)
- Table 90. Median Technologies Recent Developments
- Table 91. Cardiovascular Imaging Technologies Basic Information List
- Table 92. Cardiovascular Imaging Technologies Description and Business Overview
- Table 93. Cardiovascular Imaging Technologies Clinical Trial Imaging Products, Services and Solutions
- Table 94. Revenue (US$ Million) in Clinical Trial Imaging Business of Cardiovascular Imaging Technologies (2020-2025)
- Table 95. Cardiovascular Imaging Technologies Recent Developments
- Table 96. Banook Medical Basic Information List
- Table 97. Banook Medical Description and Business Overview
- Table 98. Banook Medical Clinical Trial Imaging Products, Services and Solutions
- Table 99. Revenue (US$ Million) in Clinical Trial Imaging Business of Banook Medical (2020-2025)
- Table 100. Banook Medical Recent Developments
- Table 101. IXICO Basic Information List
- Table 102. IXICO Description and Business Overview
- Table 103. IXICO Clinical Trial Imaging Products, Services and Solutions
- Table 104. Revenue (US$ Million) in Clinical Trial Imaging Business of IXICO (2020-2025)
- Table 105. IXICO Recent Developments
- Table 106. Tigermed Basic Information List
- Table 107. Tigermed Description and Business Overview
- Table 108. Tigermed Clinical Trial Imaging Products, Services and Solutions
- Table 109. Revenue (US$ Million) in Clinical Trial Imaging Business of Tigermed (2020-2025)
- Table 110. Tigermed Recent Developments
- Table 111. Runda Medical Basic Information List
- Table 112. Runda Medical Description and Business Overview
- Table 113. Runda Medical Clinical Trial Imaging Products, Services and Solutions
- Table 114. Revenue (US$ Million) in Clinical Trial Imaging Business of Runda Medical (2020-2025)
- Table 115. Runda Medical Recent Developments
- Table 116. Konica Minolta Basic Information List
- Table 117. Konica Minolta Description and Business Overview
- Table 118. Konica Minolta Clinical Trial Imaging Products, Services and Solutions
- Table 119. Revenue (US$ Million) in Clinical Trial Imaging Business of Konica Minolta (2020-2025)
- Table 120. Konica Minolta Recent Developments
- Table 121. Keosys Basic Information List
- Table 122. Keosys Description and Business Overview
- Table 123. Keosys Clinical Trial Imaging Products, Services and Solutions
- Table 124. Revenue (US$ Million) in Clinical Trial Imaging Business of Keosys (2020-2025)
- Table 125. Keosys Recent Developments
- Table 126. Key Raw Materials Lists
- Table 127. Raw Materials Key Suppliers Lists
- Table 128. Clinical Trial Imaging Downstream Customers
- Table 129. Clinical Trial Imaging Distributors List
- Table 130. Research Programs/Design for This Report
- Table 131. Key Data Information from Secondary Sources
- Table 132. Key Data Information from Primary Sources
List of Figures
- Figure 1. Clinical Trial Imaging Product Picture
- Figure 2. Global Clinical Trial Imaging Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
- Figure 3. Global Clinical Trial Imaging Sales Value (2020-2031) & (US$ Million)
- Figure 4. Clinical Trial Imaging Report Years Considered
- Figure 5. Global Clinical Trial Imaging Players Revenue Ranking (2024) & (US$ Million)
- Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Clinical Trial Imaging Revenue in 2024
- Figure 7. Clinical Trial Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 8. In-house Imaging Service Picture
- Figure 9. Central Imaging Service Picture
- Figure 10. Global Clinical Trial Imaging Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 11. Global Clinical Trial Imaging Sales Value Market Share by Type, 2024 & 2031
- Figure 12. Product Picture of Pharmaceutical Companies
- Figure 13. Product Picture of Biotechnology Companies
- Figure 14. Product Picture of Academic Institutes
- Figure 15. Product Picture of Others
- Figure 16. Global Clinical Trial Imaging Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 17. Global Clinical Trial Imaging Sales Value Market Share by Application, 2024 & 2031
- Figure 18. North America Clinical Trial Imaging Sales Value (2020-2031) & (US$ Million)
- Figure 19. North America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
- Figure 20. Europe Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
- Figure 21. Europe Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
- Figure 22. Asia Pacific Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
- Figure 23. Asia Pacific Clinical Trial Imaging Sales Value by Region (%), 2024 VS 2031
- Figure 24. South America Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
- Figure 25. South America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
- Figure 26. Middle East & Africa Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
- Figure 27. Middle East & Africa Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
- Figure 28. Key Countries/Regions Clinical Trial Imaging Sales Value (%), (2020-2031)
- Figure 29. United States Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
- Figure 30. United States Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- Figure 31. United States Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
- Figure 32. Europe Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
- Figure 33. Europe Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- Figure 34. Europe Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
- Figure 35. China Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
- Figure 36. China Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- Figure 37. China Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
- Figure 38. Japan Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
- Figure 39. Japan Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- Figure 40. Japan Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
- Figure 41. South Korea Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
- Figure 42. South Korea Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- Figure 43. South Korea Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
- Figure 44. Southeast Asia Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
- Figure 45. Southeast Asia Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- Figure 46. Southeast Asia Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
- Figure 47. India Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
- Figure 48. India Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
- Figure 49. India Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
- Figure 50. Clinical Trial Imaging Industrial Chain
- Figure 51. Clinical Trial Imaging Manufacturing Cost Structure
- Figure 52. Channels of Distribution (Direct Sales, and Distribution)
- Figure 53. Bottom-up and Top-down Approaches for This Report
- Figure 54. Data Triangulation
- Figure 55. Key Executives Interviewed
